Sign In
Buy A
$137.40
+2.36 (+1.75%)
At Close: Jun 03, 2026
Agilent Technologies Inc. (A) CEO Mike McMullen on Q4 2020 Results - Earnings Call Transcript
08:15pm, Monday, 23'rd Nov 2020
Agilent Technologies Inc. (A) CEO Mike McMullen on Q4 2020 Results - Earnings Call Transcript
Agilent Technologies: Q4 Earnings Insights
04:29pm, Monday, 23'rd Nov 2020
Shares of Agilent Technologies (NYSE:A) fell 2.53% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 10.11% over the past year to $0.98, which be
Agilent Reports Fourth-Quarter and Fiscal Year 2020 Financial Results; Initiates Fiscal 2021 Guidance
04:05pm, Monday, 23'rd Nov 2020
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent reports fourth-quarter and fiscal year 2020 financial results; initiates fiscal 2021 guidance.
Dividend Changes: November 14-20, 2020
09:00am, Monday, 23'rd Nov 2020
In this article series, we provide a weekly summary of dividend changes. A summary table provides relevant data and key statistics of dividend increases.
Agilent Launches New NanoDis System for Nanoparticle Dissolution Testing
08:00am, Monday, 23'rd Nov 2020
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the introduction of the NanoDis System for nanoparticle dissolution testing. Combining Agilent instrumentation
Agilent Presents Thought Leader Award to Drs. Carl H. June and Michael Milone
08:32am, Tuesday, 17'th Nov 2020
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced professors Carl H. June, MD, and Michael Milone, MD, Ph.D., as recipients of an Agilent Thought Leader Award.
Agilent Receives Expanded FDA Approval for PD-L1 IHC 22C3 pharmDx in Triple-Negative Breast Cancer
08:26pm, Friday, 13'th Nov 2020
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has received FDA approval for the use of PD-L1 IHC 22C3 pharmDx as an aid in identifying patients with trip
Agilent Collaborates With SGS to Release New US EPA Method for the Analysis of Dioxins Using GC/TQ
08:00am, Wednesday, 04'th Nov 2020
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today a collaboration with SGS has resulted in a new GC/TQ method, the SGS AXYS Method 16130, approved by the US EPA
Agilent to Webcast Fourth-Quarter Fiscal Year 2020 Financial Results Presentation, Sets Date for Virtual Analyst and Investor Meeting
03:00pm, Thursday, 29'th Oct 2020
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent will release fiscal fourth quarter financial results Mon., Nov. 23. and will also host a virtual analyst and investor event Wed., Dec. 9.
Bill Ackman Reduces Lowe's, Agilent Technologies and Hilton Worldwide Holdings
05:15pm, Monday, 26'th Oct 2020
Bill Ackman (Trades, Portfolio), leader of Pershing Square Capital Management, has revealed his portfolio for the third quarter.
Pacer Advisors Inc. Sells 4,329 Shares of Agilent Technologies, Inc. (NYSE:A)
07:41am, Thursday, 22'nd Oct 2020
Pacer Advisors Inc. lowered its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 13.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commi
Agilent Technologies, Inc. (NYSE:A) Shares Purchased by IBM Retirement Fund
06:40am, Tuesday, 20'th Oct 2020
IBM Retirement Fund boosted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 39.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and
Validation of Bluestar Genomics’ Technology for Non-Invasive Detection of Pancreatic Cancer Published in Nature Communications
12:00am, Tuesday, 20'th Oct 2020
Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches to early cancer detection, announced today t
Mission Wealth Management LP Buys 101 Shares of Agilent Technologies, Inc. (NYSE:A)
06:18am, Monday, 19'th Oct 2020
Mission Wealth Management LP increased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 1.1% in the third quarter, according to the company in its most recent Form 13F filing with the SEC
